Paul R. Finley

525 total citations
25 papers, 414 citations indexed

About

Paul R. Finley is a scholar working on Surgery, Hematology and Emergency Medicine. According to data from OpenAlex, Paul R. Finley has authored 25 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Hematology and 4 papers in Emergency Medicine. Recurrent topics in Paul R. Finley's work include Poisoning and overdose treatments (3 papers), Pregnancy and preeclampsia studies (2 papers) and Muscle Physiology and Disorders (2 papers). Paul R. Finley is often cited by papers focused on Poisoning and overdose treatments (3 papers), Pregnancy and preeclampsia studies (2 papers) and Muscle Physiology and Disorders (2 papers). Paul R. Finley collaborates with scholars based in United States, New Zealand and Germany. Paul R. Finley's co-authors include DOUGLAS LINDSEY, Thomas R. Navin, James M. Byers, Kenneth A. Conrad, Philip Scuderi, Milton G. Ettinger, Robert A. Peterson, M. Andrew Levitt, John B. Sullivan and S. Michael Owens and has published in prestigious journals such as CHEST Journal, Clinical Chemistry and European Journal of Immunology.

In The Last Decade

Paul R. Finley

24 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul R. Finley United States 12 92 90 62 50 45 25 414
K. W. Rumpf Germany 15 110 1.2× 37 0.4× 79 1.3× 95 1.9× 48 1.1× 38 534
Frank A. Krumlovsky United States 11 96 1.0× 41 0.5× 115 1.9× 25 0.5× 44 1.0× 35 492
James H. Knepshield United States 8 43 0.5× 110 1.2× 69 1.1× 34 0.7× 21 0.5× 17 354
Anthony Killian United States 11 98 1.1× 39 0.4× 50 0.8× 26 0.5× 71 1.6× 17 376
R. Lee West United States 12 230 2.5× 49 0.5× 87 1.4× 56 1.1× 19 0.4× 18 574
Watson C. Arnold United States 12 95 1.0× 33 0.4× 89 1.4× 52 1.0× 45 1.0× 35 450
P. Tréchot France 10 90 1.0× 38 0.4× 57 0.9× 14 0.3× 31 0.7× 65 381
D Naidoo Australia 12 53 0.6× 28 0.3× 21 0.3× 58 1.2× 21 0.5× 22 511
Emine Şamdancı Türkiye 14 124 1.3× 60 0.7× 70 1.1× 64 1.3× 38 0.8× 80 558
Paul Kubler Australia 12 101 1.1× 23 0.3× 71 1.1× 45 0.9× 25 0.6× 34 489

Countries citing papers authored by Paul R. Finley

Since Specialization
Citations

This map shows the geographic impact of Paul R. Finley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Finley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Finley more than expected).

Fields of papers citing papers by Paul R. Finley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul R. Finley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Finley. The network helps show where Paul R. Finley may publish in the future.

Co-authorship network of co-authors of Paul R. Finley

This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Finley. A scholar is included among the top collaborators of Paul R. Finley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Finley. Paul R. Finley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Mark A., Wayne J. Morgan, Paul R. Finley, & Philip Scuderi. (1991). Circulating levels of tumor necrosis factor and interleukin‐1 in cystic fibrosis. Pediatric Pulmonology. 10(2). 86–91. 27 indexed citations
2.
Weinstein, Louis, et al.. (1991). Characterization of Ascites Present at Cesarean Section. American Journal of Perinatology. 8(2). 99–102. 14 indexed citations
3.
Weinstein, Louis, et al.. (1990). Plasma Levels of Fibronectin and Prostacyclin Metabolite in Peripartum Preeclamptic Women. American Journal of Perinatology. 7(2). 125–129. 10 indexed citations
4.
Scuderi, Philip, et al.. (1990). Regulation of Tumor Necrosis Factor Secretion in Leukocytes from Alpha-1-Antitrypsin Deficient Humans. Immunological Investigations. 19(5-6). 453–461. 1 indexed citations
5.
Scuderi, Philip, Robert T. Dorr, James D. Liddil, et al.. (1989). Alpha‐globulins suppress human leukocyte tumor necrosis factor secretion. European Journal of Immunology. 19(5). 939–942. 44 indexed citations
6.
Christenson, Robert H., et al.. (1989). Immunochemical assays for IgG, IgA, IgM and transferrin compared. Clinical Biochemistry. 22(4). 271–276. 2 indexed citations
7.
Sandyk, Reuven, Colin R. Bamford, Anna Binkiewicz, & Paul R. Finley. (1988). Gonadotropin Deficiency in Tourette's Syndrome: A Preliminary Communication. International Journal of Neuroscience. 42(1-2). 121–125. 14 indexed citations
8.
Sampliner, Richard E., Donald Perrier, Robert Powell, & Paul R. Finley. (1984). Influence of Ascites on Tobramycin Pharmacokinetics. The Journal of Clinical Pharmacology. 24(1). 43–46. 17 indexed citations
9.
Stern, Lawrence Z., et al.. (1984). Increased activities of MB and BB isozymes of creatine kinase in denervated neonatal and adult rat muscle. Experimental Neurology. 83(3). 640–645. 4 indexed citations
10.
Nau, Heinz, Paul R. Finley, Jane Williams, & Klaus Brendel. (1983). Valproic acid pharmacokinetics in the mouse following controlled‐release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirs. Biopharmaceutics & Drug Disposition. 4(2). 173–182. 7 indexed citations
11.
Wirt, Daniel P., Thomas M. Grogan, Claire M. Payne, et al.. (1983). Phagocytic, Lambda Light Chain, Plasma Cell Myeloma. American Journal of Clinical Pathology. 80(1). 75–84. 11 indexed citations
12.
Conrad, Kenneth A., et al.. (1983). Lidocaine elimination: Effects of metoprolol and of propranolol. Clinical Pharmacology & Therapeutics. 33(2). 133–138. 58 indexed citations
13.
Weinstein, Louis, Caroline Anderson, Paul R. Finley, & D A Lichti. (1982). The in utero management of urinary outflow tract obstruction. Journal of Clinical Ultrasound. 10(9). 465–468. 12 indexed citations
14.
Fenster, Paul E., et al.. (1982). Kinetics of the digoxin-aspirin combination. Clinical Pharmacology & Therapeutics. 32(4). 428–430. 10 indexed citations
15.
Hicks, Mary Jane, et al.. (1982). Rheumatoid Factor Activity by Rate Nephelometry Correlated with Clinical Activity in Rheumatoid Arthritis. American Journal of Clinical Pathology. 78(3). 342–345. 6 indexed citations
16.
Karpman, Robert R., et al.. (1981). Serum CPK Isoenzyme BB as an Indicator of Brain Tissue Damage following Head Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 21(2). 148–151. 7 indexed citations
17.
LINDSEY, DOUGLAS, Thomas R. Navin, & Paul R. Finley. (1978). Transient Elevation of Serum Activity of MB Isoenzyme of Creatine Phosphokinase in Drivers Involved in Automobile Accidents. CHEST Journal. 74(1). 15–18. 48 indexed citations
18.
Finley, Paul R., et al.. (1977). Computer-Assisted Analysis of Clinical Chemistry Quality Control Data. Laboratory Medicine. 8(6). 24–31.
19.
Peterson, Robert A., et al.. (1970). Changes in Antithrombin III and Plasminogen Induced by Oral Contraceptives. American Journal of Clinical Pathology. 53(4). 468–473. 39 indexed citations
20.
Finley, Paul R., et al.. (1967). Electronic Data Processing in a Private Hospital Laboratory. American Journal of Clinical Pathology. 48(6). 575–589. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026